Puma Biotechnology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Puma Biotechnology using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $0.21 | $0.08 | 162.5 % |
| Q2 | 2025-08-07 | $0.15 | $0.07 | 114.3 % |
| Q1 | 2025-05-08 | $0.10 | $0.03 | 233.3 % |
| Q4 | 2025-02-27 | $0.43 | $0.14 | 207.1 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $54.50M | $49.95M | 9.11 % |
| Q2 | 2025-08-07 | $49.20M | $51.27M | -4.04 % |
| Q1 | 2025-05-08 | $46.00M | $44.55M | 3.25 % |
| Q4 | 2025-02-27 | $59.10M | $52.50M | 12.6 % |
Puma Biotechnology (PBYI) is scheduled to report earnings on February 26, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
The Actual EPS was $0.21, which beat the estimate of $0.08.
The Actual Revenue was $54.5M, which beat the estimate of $49.9M.
Browse earnings estimates, EPS, and revenue on all stocks.